X·CON 2019 – Healthtech →
Serial Entrepreneur and Investor
President and CEO of the Central Indiana Corporate Partnership
Professor, Michigan State University
Software Engineer at Skelmir
Vice President for Research at UT Health Science Center at San Antonio
Managing Director, D.E. Shaw and Co., L.P.
Director, Life Sciences Institute, University of Michigan
October 15, 2019 · New York
October 17, 2019 · Boston
October 22, 2019 · Boston
Graphic of a Pentarin, a miniature type of drug conjugate developed by Tarveda Therapeutics.
Xconomy Insight · Webinar
Potential cures and treatments for diseases are on the horizon for a growing number of patients, thanks to recent breakthroughs in CRISPR gene-editing technologies and in cell and gene therapy.
Sponsored · Whitepaper
Implementing electronic solutions for risk mitigation
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
Tax credits help tech innovators attract capital, fuel growth
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.